University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 9L-11-8


HLA-Mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High-Risk Acute Myeloid Leukemia.

Type: Treatment
Phase: Pilot
Status: Open to Accrual
Treatments: Chemotherapy: Systemic, Other
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Ann Mohrbacher, M.D.
Other Trial Staff:  Ibrahim Syed, D.M., Ibrahim Syed, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.